WEISS K H ET AL: "WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial", JOURNAL OF HEPATOLOGY, vol. 66, no. 1, Suppl. S, April 2017 (2017-04-01), & INTERNATIONAL LIVER CONGRESS / 52ND ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-THE-LIVER; AMSTERDAM, NETHERLANDS; APRIL 19 -23, 2017, pages S88, XP085011522, ISSN: 0168-8278 (B1)

WEISS KARL HEINZ ET AL: "Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.", THE LANCET. GASTROENTEROLOGY & HEPATOLOGY 12 2017, vol. 2, no. 12, 5 October 2017 (2017-10-05), pages 869 - 876, XP009511454, ISSN: 2468-1253 (B1)

SCHILSKY MICHAEL L ET AL: "An Ongoing Extension of a Phase 2 Study of WTX101 in Newly Diagnosed Wilson Disease Patients", HEPATOLOGY, vol. 66, no. Suppl. 1, Sp. Iss. SI, October 2017 (2017-10-01), & 68TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-THE-STUDY-OF-LIVER-DISEASES (AASLD) / LIVER MEETING; WASHINGTON, DC, USA; OCTOBER 20 -24, 2017, pages 429A, XP002789220, ISSN: 0270-9139 (B1)

WO-A2-2007/084818 (B1)

"Posters Thursday, 12 April 2018 ED - Zoulim Fabien", JOURNAL OF HEPATOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 68, 28 March 2018 (2018-03-28), XP085370986, ISSN: 0168-8278, DOI: 10.1016/S0168-8278(18)30428-8 (B1)

WO-A2-2004/009034 (B1)